Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Estimating the Attributable Risk of Vascular Disorders in Different Ranges of Fasting Plasma Glucose and Assessing the Effectiveness of Anti-Diabetes Agents on Risk Reduction; Questioning the Current Diagnostic Criteria
Hamideh Salimzadeh Hosseinabad
Hamideh Salimzadeh Hosseinabad

Assistant Professor of Health Education and Promotion

Digestive Diseases Research Center

Tehran University of Medical Sciences

All Documents
1. Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study, Archives of Iranian Medicine (2023)
2. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
3. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
4. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
5. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
6. Diabetes Mortality and Trends Before 25 Years of Age: An Analysis of the Global Burden of Disease Study 2019, The Lancet Diabetes and Endocrinology (2022)
7. Estimates, Trends, and Drivers of the Global Burden of Type 2 Diabetes Attributable to Pm2·5 Air Pollution, 1990–2019: An Analysis of Data From the Global Burden of Disease Study 2019, The Lancet Planetary Health (2022)
8. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
9. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
10. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
11. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
12. Population-Level Risks of Alcohol Consumption by Amount, Geography, Age, Sex, and Year: A Systematic Analysis for the Global Burden of Disease Study 2020, The Lancet (2022)
13. Population-Level Risks of Alcohol Consumption by Amount, Geography, Age, Sex, and Year: A Systematic Analysis for the Global Burden of Disease Study 2020, The Lancet (2022)
14. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
15. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
16. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
17. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
18. Global, Regional, and National Mortality Among Young People Aged 10–24 Years, 1950–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2021)
19. Global, Regional, and National Mortality Among Young People Aged 10–24 Years, 1950–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2021)
20. Global, Regional, and National Progress Towards Sustainable Development Goal 3.2 for Neonatal and Child Health: All-Cause and Cause-Specific Mortality Findings From the Global Burden of Disease Study 2019, The Lancet (2021)
21. Global, Regional, and National Progress Towards Sustainable Development Goal 3.2 for Neonatal and Child Health: All-Cause and Cause-Specific Mortality Findings From the Global Burden of Disease Study 2019, The Lancet (2021)
22. Measuring Routine Childhood Vaccination Coverage in 204 Countries and Territories, 1980–2019: A Systematic Analysis for the Global Burden of Disease Study 2020, Release 1, The Lancet (2021)
23. Spatial, Temporal, and Demographic Patterns in Prevalence of Chewing Tobacco Use in 204 Countries and Territories, 1990-2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Public Health (2021)
24. Spatial, Temporal, and Demographic Patterns in Prevalence of Chewing Tobacco Use in 204 Countries and Territories, 1990-2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Public Health (2021)
25. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
26. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
27. Association of Dna Repair Gene Variants With Colorectal Cancer: Risk, Toxicity, and Survival, BMC Cancer (2020)
28. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)
29. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)
30. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)
31. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)
32. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
33. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
34. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
35. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
36. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
37. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
38. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
39. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
40. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
41. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
42. Mapping Child Growth Failure Across Low- and Middle-Income Countries, Nature (2020)
43. Mapping Disparities in Education Across Low- and Middle-Income Countries, Nature (2020)
44. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
45. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
46. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)
47. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)
48. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
49. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
50. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)
51. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)
52. The Global, Regional, and National Burden of Gastro-Oesophageal Reflux Disease in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
53. The Global, Regional, and National Burden of Oesophageal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
54. The Global, Regional, and National Burden of Stomach Cancer in 195 Countries, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
55. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
56. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
57. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncology (2019)
58. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
59. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
60. Predictive Factors of Advanced Colonic Adenomas and Cancer Using Data Mining, Middle East Journal of Digestive Diseases (2019)
61. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
62. The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
63. Annual Trends of Gastrointestinal Cancers Mortality in Iran During 1990-2015; Nasbod Study, Archives of Iranian Medicine (2018)
64. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
65. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
66. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 a Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration, JAMA Oncology (2018)
67. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
68. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
69. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
70. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
71. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
72. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
73. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
74. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
75. Motivational Interviewing and Screening Colonoscopy in High-Risk Individuals. a Randomized Controlled Trial, Patient Education and Counseling (2018)
76. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
77. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
78. Cancer Research Priorities and Gaps in Iran: The Influence of Cancer Burden on Cancer Research Outputs Between 1997 and 2014, Public Health (2017)
79. Cancer Screening Awareness and Practice in a Middle Income Country; a Systematic Review From Iran, Asian Pacific Journal of Cancer Prevention (2017)
80. Cost-Effectiveness of Screening Colonoscopy in Iranian High Risk Population, Archives of Iranian Medicine (2017)
81. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran, Archives of Iranian Medicine (2017)
82. Advanced Colonic Neoplasia in the First Degree Relatives of Colon Cancer Patients: A Colonoscopy-Based Study, International Journal of Cancer (2016)
83. Cancer Risk Awareness and Screening Uptake in Individuals at Higher Risk for Colon Cancer: A Cross-Sectional Study, BMJ Open (2016)